The human cytomegalovirus chemokine receptor US28 mediates vascular smooth muscle cell migration

Daniel N. Streblow, Cecilia Soderberg-Naucler, Jeffrey Vieira, Patricia Smith, Eiko Wakabayashi, Franziska Ruchti, Kirsten Mattison, Yoram Altschuler, Jay A. Nelson

Research output: Contribution to journalArticle

324 Scopus citations

Abstract

Human cytomegalovirus (HCMV) infection of smooth muscle cells (SMCs) in vivo has been linked to a viral etiology of vascular disease. In this report, we demonstrate that HCMV infection of primary arterial SMCs results in significant cellular migration. Ablation of the chemokine receptor, US28, abrogates SMC migration, which is rescued only by expression of the viral homolog and not a cellular G protein-coupled receptor (GPCR). Expression of US28 in the presence of CC chemokines including RANTES or MCP-1 was sufficient to promote SMC migration by both chemokinesis and chemotaxis, which was inhibited by protein tyrosine kinase inhibitors. US28-mediated SMC migration provides a molecular basis for the correlative evidence that links HCMV to the acceleration of vascular disease.

Original languageEnglish (US)
Pages (from-to)511-520
Number of pages10
JournalCell
Volume99
Issue number5
DOIs
StatePublished - Nov 24 1999

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)

Fingerprint Dive into the research topics of 'The human cytomegalovirus chemokine receptor US28 mediates vascular smooth muscle cell migration'. Together they form a unique fingerprint.

  • Cite this

    Streblow, D. N., Soderberg-Naucler, C., Vieira, J., Smith, P., Wakabayashi, E., Ruchti, F., Mattison, K., Altschuler, Y., & Nelson, J. A. (1999). The human cytomegalovirus chemokine receptor US28 mediates vascular smooth muscle cell migration. Cell, 99(5), 511-520. https://doi.org/10.1016/S0092-8674(00)81539-1